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Abstract
Background: Neonatal tetanus (NT) is still considered as one of the major causes of neonatal
death in many developing countries. The aim of the present study was to assess the characteristics
of sixty-seven infants with the diagnosis of neonatal tetanus followed-up in the Pediatric Infectious
Diseases Ward of Dicle University Hospital, Diyarbakir, between 1991 and 2006, and to draw
attention to factors that may contribute (or may have contributed) to the elimination of the disease
in Diyarbakir.
Methods:  The data of sixty-seven infants whose epidemiological and clinical findings were
compatible with neonatal tetanus were reviewed. Patients were stratified into two groups
according to whether they survived or not to assess the effect of certain factors in the prognosis.
Factors having a contribution to the higher rate of tetanus among newborn infants were discussed.
Results: A total of 55 cases of NT had been hospitalized between 1991 and 1996 whereas only 12
patients admitted in the last decade. All of the infants had been delivered at home by untrained
traditional birth attendants (TBA), and none of the mothers had been immunized with tetanus
toxoid during her pregnancy. Twenty-eight (41.8%) of the infants died during their follow-up.
Lower birth weight, younger age at onset of symptoms and at the time admission, the presence of
opisthotonus, risus sardonicus and were associated with a higher mortality rate.
Conclusion: Although the number of neonatal tetanus cases admitted to our clinic in recent years
is lower than in the last decade efforts including appropriate health education of the masses,
ensurement of access to antenatal sevices and increasing the rate of tetanus immunization among
mothers still should be made in our region to achieve the goal of neonatal tetanus elimination.
Background
Neonatal tetanus (NT), a preventable disease, remains
one of the major causes of neonatal death in many devel-
oping countries [1-3]. It is an acute disease characterized
by generalized rigidity and convulsive spasms of skeletal
muscles, and is caused by an exotoxin of the bacterium
Clostridium tetani which is a gram-positive and anaerobic
rod forming spores that are very resistant to heat and the
usual antiseptics [4].
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Tetanus in neonates is primarily caused by lack of hygiene
during delivery, and it usually occurs when the umbilical
cord is contaminated while it is being cut with a non-ster-
ile instrument, or dressed. Complete eradication of teta-
nus is not possible as the spores of C. tetani are
widespread in soil and in the stools of people and ani-
mals, and can be transmitted without human contact. The
disease can be prevented by immunizing pregnant
women and women of childbearing age with tetanus tox-
oid. Following appropriate vaccination of the mother,
antibodies pass to the fetus across the placenta and pro-
vide protection against NT [1,3,5].
NT has been reported to be virtually eliminated from
developed countries [2]. However, it continues to be a
leading cause of neonatal mortality in developing coun-
tries. Even with treatment, the case fatality rate can be as
high as 80–90% [6,7]. As the second leading cause of
death from vaccine-preventable diseases among children
world-wide, NT is responsible for 14 percent (215,000) of
all neonatal deaths [1,8].
In 1989, the World Health Assembly called for the elimi-
nation of NT [9]. The year 2005 was set as the target date
for worldwide elimination of the disease by UNICEF,
WHO and the United Nations Population Fund. In 2000,
WHO reported 57 countries, including Turkey, not to
have achieved elimination of the disease (Global elimina-
tion of NT is defined as the reduction of cases to less than
1 per 1000 live births in every district in every country). In
its report, WHO stressed that district assessment must
confirm the achievement of NT elimination in the coun-
tries seeming to have done so [1].
Effective implementation of public health measures in the
past decade has reduced the incidence of NT in Turkey
[10-12]. However, as of mid-2000, Turkey was reported
by WHO not to have achieved elimination of the disease
yet although it was ranked among the six countries to have
potentially eliminated NT [1]. The aim of the present
study was to evaluate the clinical findings, risk factors and
prognostic characteristics of sixty-seven infants with the
diagnosis of NT hospitalized and followed-up in the Pedi-
atric Infectious Diseases Ward of Dicle University Hospi-
tal, Diyarbakir, between 1991 and 2006, and to draw
attention to factors that may contribute (or may have con-
tributed) to the elimination of the disease in our region.
Methods
The characteristics of sixty-seven infants diagnosed as NT
and followed-up in Pediatric Infectious Diseases Ward of
Dicle University Hospital, Diyarbakir (the largest tertiary
center in the Southeast Anatolian Region of Turkey) from
1991 to 2006 were reviewed using their clinical charts.
Most of the patients had been referred from state hospitals
and primary health centers. The epidemiological and clin-
ical findings of all the patients were compatible with neo-
natal tetanus. Nuchal rigidity, spasticity, muscular spasm,
trismus and opisthotonus were included in the criteriae
for clinical diagnosis, and the presence of at least three of
these was accepted as compatible with tetanus [13]. The
diagnosis was maintained on the basis of WHO criteriae
[14]. In order to investigate metabolic diseases, serum lac-
tic acid, pyruvic acid, and ammonia levels were assessed
and urine/blood aminoacid chromatography was per-
formed. In all cases, metabolic screening yielded negative
results.
The infants received treatment in specially designed
rooms inside the neonatal care unit meeting the require-
ment of a quiet and dark place. They received all treatment
with human tetanus immunoglobulin (3000 U intramus-
cular injection) or equine tetanus antitoxin (50000 U
with half given intramuscularly and half intravenously),
and, depending on which was available after appropriate
testing, antimicrobial therapy with penicillin G (100,000
IU/kg/day) or with metronidazole, and high dose
diazepam (40 mg/kg/day) intravenously. Intravenous
fluid was administered until the patients could tolerate
nasogastric feeding. Routine microbiologic and biochem-
ical tests were ordered. Besides the age, sex and birth
weight of the patients, data including the age at the onset
of symptoms, the age at hospital admission, instruments
used to cut the umbilical cord, place of delivery (home or
hospital), the vaccination status of the mothers with teta-
nus toxoid (TT), clinical signs and symptoms and treat-
ment procedures were all recorded.
Patients were stratified into two groups according to
whether they survived or not (group I and II, group I con-
sisting of surviving infants) to assess the effect of certain
factors in the prognosis. Factors having a contribution to
the occurrence of high rate of tetanus among newborn
infants were discussed. For statistical analysis, SPSS (Sta-
tistical Package for Social Sciences) 10.0 program was
used. Normally distributed data were expressed as mean ±
SD and analyzed with Student's t test. Categorical data
were analyzed by chi-square test. For the correlation anal-
ysis, Spearman's correlation test, and for risk assessments,
odds ratio (OR; 95%CI: confidence interval) and logistic
regression analysis were done. Results are given as mean ±
SD, and p < 0.05 is accepted as significant.
Results
Sixty-seven infants (48 males and 19 females) were
included in the study. In their article published in Euro-
pean Journal of Epidemiology in 1999, our colleques had
reported a total of 55 cases of NT to have been hospital-
ized in the Pediatric Infectious Diseases Ward of our hos-
pital between 1991 and 1996 [10]. However, in the lastBMC Infectious Diseases 2008, 8:112 http://www.biomedcentral.com/1471-2334/8/112
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decade (between 1996 and 2006), only 12 new cases have
been documented in the same clinic showing a tremen-
dous decline in the incidence. The mean age of the
patients was 8.9 ± 4.3 days at admission. The mean birth
weight of the cases was 3125 ± 420 g. Twenty-eight
(41.8%) of the infants [20 of the boys (41.7%), and 8 of
the girls (42.1%)] died during their follow-up. The mean
age at death in deceased infants was 7.4 ± 3.4 days. For the
group of surviving infants, the mean birth weight was
found 3402 ± 515 g whereas the birth weight of the
deceased cases was 3153 ± 462 g, the difference being sta-
tistically significant (p = 0.014) (Table 1). The sex of the
infants was not found to be statistically significant (Table
1).
The mean age at the onset of symptoms was 5.8 ± 3.1
days. Infants who survived had a mean age of 7.0 ± 4.0
days when the symptoms first occurred, whereas the mean
age at the onset of the symptoms was 4.9 ± 1.9 days in the
non-surviving group. The mean age when the symptoms
first appeared was significantly lower in the non-surviving
infants than in the surviving ones (p < 0.0001) (Table 1).
Among the surviving infants, the mean age at admission
was noted as 10.3 ± 4.7 days, whereas it was 7.4 ± 3.4 days
for the non-surviving ones. This difference was also found
to be statistically significant (p = 0.001) (Table 1).
The main clinical signs and symptoms of the infants were
spasticity (54 infants; 81%), lack of sucking (49 infants;
73%), trismus (38 infants; 57%), fever (28 infants; 42%),
omphalitis (27 infants; 40%), jaundice (19 infants; 28%),
risus sardonicus (17 infants; 26%), irritability (14 infants;
21%), cyanosis (9 infants; 13%) and opisthotonus (9
infants; 13%) in decreasing order. Signs which were found
to be related with fatal outcome were opisthotonus (p =
0.001) and risus sardonicus (p = 0.001) (Table 1).
There was negative correlation between age and mortality
(r = -0.63, p < 0.0001) whereas there were positive corre-
lations between opisthotonus and mortality (r = 0.44, p <
0.0001), and risus sardonicus and mortality (r = 0.45, p <
0.0001). Opisthotonus was seen 13,9 times more in non-
survivors [odds ratio (OR) = 13.9, 95% CI =
1.890–102.660]. Additionally, risus sardonicus was
detected 6 times less in survivors [OR= 6.04, 95%CI =
1.896–19.209]. However, in logistic regression analysis in
which age at admission (days), gender, birth weight, spas-
ticity, fever, opisthotonus, lack of sucking, trismus,
omphalitis, irritability, cyanosis, jaundice, risus sardoni-
cus and initial day of symptoms were included in the anal-
ysis as confounding factors, only age at admission (days)
was found as an independent risk factor for mortality
[odds ratio (OR) = 5.288, 95% CI = 1.730–16.165] (Table
2).
All of the patients came from rural areas, and all of them
had been delivered by untrained traditional birth attend-
ants (TBA). None of the mothers had received antenatal
care in a clinic before delivery, and none had been immu-
nized with TT during her pregnancy. The instrument to cut
the umbilical cord was noted as razor blade in 37 infants
(55.2%), scissors in 18 infants (26.9%) and knife in 12
patients (17.9%). All of these instruments had been used
in non-hygienic conditions before.
Discussion
Reducing deaths from NT has been regarded as one of the
simplest and most cost-effective ways to reduce the neo-
natal mortality rate. The disease can be effectively pre-
Table 1: Clinical signs, symptoms and characteristics of the patients with neonatal tetanus
Variables Survivors (n 39) Deaths (n 28) p value
Birth weight, g, (SD)* 3402 ± 515 3153 ± 462 = 0.014
Age at admission, days, (SD)* 10.3 ± 4.7 7.4 ± 3.4 = 0.001
Age at onset of symptoms, days, (SD)* 7.0 ± 4.0 4.9 ± 1.9 < 0.0001
Male/female(n)∞ 28/11 20/8 NS
Spasticity(n)∞ 30 24 NS
Lack of sucking(n)∞ 28 21 NS
Trismus(n)∞ 22 16 NS
Fever (n)∞ 15 13 NS
Omphalitis∞ 16 11 NS
Jaundice∞ 11 8 NS
Risus sardonicus∞ 3 8 < 0.0001
Irritability∞ 86 N S
Opisthotonus∞ 1 8 < 0.0001
Cyanosis∞ 54 N S
* Student t test
∞ Chi-square test
NS: non-significantBMC Infectious Diseases 2008, 8:112 http://www.biomedcentral.com/1471-2334/8/112
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vented through the use of tetanus toxoid. In addition to
immunization, promotion of clean deliveries and
improvement of surveillance are the main strategies to
achieve its elimination [1].
NT occurs most commonly in the lowest income coun-
tries and those with the least developed health infrastruc-
ture [1]. Over the past decade, progress in reducing the
incidence of tetanus has been substantial. According to
WHO, 309,000 people are estimated to have died of teta-
nus in 2000 [15], including 200,000 cases of NT [16], a
reduction of about 75% when compared to 1988.
The disease has also been reduced geographically: whereas
in 1994 a total of 82 countries were accepted as not having
eliminated NT [16], the focus has recently been on 57
countries that were reported not to have achieved elimina-
tion of the disease in 2000 by WHO. Turkey is included
among these 57 countries. According to 1999 WHO esti-
mates, 231 cases of maternal and NT occurred in this
country. However in 2000, Turkey was ranked by WHO as
one of the six countries to have potentially eliminated the
disease. However, district assessments are necessary to
confirm that elimination has been achieved [1].
With specific therapy for neonatal tetanus, lethality rates
have been reported to range from 25 to 90% [17]. The
overall case fatality rate was found 41.8% in our patients
with similar death rates for male and female infants (a
male/female death ratio of 0.99:1.00). In their survey in a
district of Pakistan, Quddus et al found the case fatality
rate among 43 NT cases admitted to the district hospital as
62% (18) whereas Asekun-Olerinmoye et al found a case
fatality rate of 79.4% in their study which was conducted
on 120 cases and included all secondary and tertiary hos-
pitals in Ibadan, Nigeria [19]. In two other studies, both
carried out in Turkey, Ertem et al and Totan et al found
fatality rates of 40.0 and 70.4%, respectively [20,21]. In
the United States where 201 cases of NT were reported
during 1991–94, fatality rate was found to be relatively
low (25%) [22].
In the studies carried out by Basu et al and Anita et al, low
body weight was found to be a risk factor for mortality in
neonatal tetanus [6,23]. Although there was significant
difference between surviving infants and deceased ones
regarding body weight in our study we could not show
that it constituted a risk factor for mortality.
Male infants constituted 71.6% of our patients. Higher
proportion of neonatal deaths due to tetanus among
males than females were reported previously [20-26].
Studies conducted in Pakistan, Sudan and Egypt showed
that unhygienic practices during circumcision were
responsible for this disparity in the proportion of male
and female NT deaths [24,25]. Besides, we think that the
lack of records due to underrated and neglected female
neonates in underdeveloped populations may contribute
to such a disparity. Regarding the case fatality rates, there
was no difference between male and female patients in
our study.
There are many reports stating that mortality increased
considerably when the incubation period was 5–10 days
or less [6,19,20,23]. Short incubation period may show
increased virulence of the infectious agent, or it may des-
ignate decreased defense mechanisms of the host against
the disease. Both of these conditions may lead to an
increase in mortality in neonatal tetanus cases. In our
study, there was negative correlation between age of the
patient and mortality. The difference regarding the mean
age at admission between survivors and non-survivors
was statistically significant, and young age at admission
was shown to be a risk factor for mortality. [odds ratio
(OR) = 5.288, 95% CI = 1.730–16.165]. This coincides
with the findings of previous studies.
Another important result of this study is the finding of a
powerful correlation between risus sardonicus and mor-
tality, and opisthotonus and mortality. Opisthotonus was
seen 13.9 times more in non-survivors (OR = 13.9, 95%
CI = 1.890–102.660). Additionally, risus sardonicus was
detected 6 times less in survivors (OR= 6.04, 95%CI =
1.896–19.209). A powerful correlation between both of
these factors and mortality has been pointed out in few
studies before. In their study, Basu et al considered risus
sardonicus (OR = 4.5, 95%CI = 2.4–8.6). and generalized
rigidity (OR = 3.8, 95%CI = 2.3–6.2) to be a negative risk
factor for prognosis [6].
Table 2: Multivariate analysis of risk factors neonatal tetanus.
Variables Odds ratio 95% CI
Birth weight, g 0.9 0.1–1.5
Age at admission 5.2* 1.7–16
Age at onset of symptoms 0.6 0.3–1
Gender 1.2 0.3–4
Spasticity 1.1 0.2–7
Lack of sucking 0.8 0.2–3
Trismus 0.7 0.1–1.2
Fever 0.4 0.4–5
Omphalitis 0.5 0.1–5
Jaundice 0.1 0.1–15
Risus sardonicus 1.8 0.1–20
Irritability 0.9 0.5–30
Opisthotonus 1.3 0.5–1.9
Cyanosis 0.4 0.4–3
* Statistically significant, p < 0.05.BMC Infectious Diseases 2008, 8:112 http://www.biomedcentral.com/1471-2334/8/112
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Illiteracy of the parents, poor antenatal care, unhygienic
delivery practices and low immunization coverage with
tetanus toxoid have all been shown to contribute to the
occurrance of NT cases [1,6,18,20,21,27,28]. In our study,
none of the mothers had received antenatal care before,
and none of the cases was born by a clean delivery which
is defined as a birth attended by professional health staff
[1]. The unhygienic use of instruments to cut the cord is
alarming and likely to be a cause of contamination by tet-
anus spores in our cases. It is of critical importance that
the health workers giving tetanus toxoid vaccinations to
these women also inform them about the components of
clean delivery and post-delivery practices, especially
umbilical cord care and discourage harmful traditional
practices [1].
All of the infants in our study came from rural areas. How-
ever, in the survey of Ertem et al [21] which analysed the
data of 56 children with NT admitted to Diyarbakir Chil-
dren State Hospital between 1994 and 2001, 17 (30.4%)
of the patients came from urban areas. This reflects the
persisting risk for NT in city centres as well although the
vaccination coverage is higher, and the availability of
appropriate delivery practices is easier in the city centres.
However, in accordance with our findings, all of the NT
cases in that study were born at home with the help of
unqualified midwives [21]. These observations pinpoint
the need for health education in all communities, both
rural and urban.
In 1994, the Turkish Ministry of Health launched an
immunization program that targeted pregnant women
[29]. This program required that all non-immunized
women be vaccinated with two doses of TT during their
first pregnancy and with one dose during each subsequent
pregnancy. Strikingly, none of the mothers of our cases
had been immunized with TT during her pregnancy.
According to the Ministry of Health, reported coverages of
vaccination for pregnant women with TT2 (the second
dose of TT) in 2000 and 2001 were 52 and 50% in Sam-
sun, 65 and 65% in Antalya, and 8 and 11% in Diyarbakir,
respectively [30,31]. In a recent study carried out in three
selected provinces of Turkey (Samsun, Antalya and Diyar-
bakir), Kurtoglu et al. found that the presence of protec-
tive antibody levels against tetanus in women of
childbearing age ranged between 56.5–91.4% in different
age groups [32], with lowest percentages having been
recorded in Diyarbakir. These data may indicate the insuf-
ficiency of the immunization service in Diyarbakir during
last years, and clearly elucidate the need to expand immu-
nization services in our province in order to achieve the
goals of the neonatal elimination program.
In their article published in European Journal of Epidemi-
ology in 1999, our colleques had reported a total of 55
cases of NT to had been hospitalized in the Pediatric Infec-
tious Diseases Ward of our hospital between 1991 and
1996 [10]. However, between 1996 and 2006, only 12
new cases have been documented in the same clinic. Tur-
key has in fact experienced a reduction in the incidence of
NT through effective implementation of public health
measures in the past decade [10-12]. Though, in spite of
the observation that the number of NT cases admitted to
our clinic has declined compared to the last decade
[10,27], we think that efforts still should be made in our
region to achieve the goal of NT elimination.
Limitations of the study
Among our patients, there is a significantly higher per-
centage of males presenting than females, although no
difference was found in case fatality. This could be due to
gender bias in care seeking. Since about half the infants
survived, we examined differences in those who survived
and those who did not. However, there could still be
biases associated with presentation that would make it
difficult to know whether these were real differences.
Another limitation to this study is the fact there is no con-
trol group.
Conclusion
Surveillance of the disease to identify high risk districts
and areas, providing the masses with appropriate health
education in addition to ensuring access to antenatal serv-
ices, improving the quality of such services, and extending
efforts to provide tetanus immunisation to mothers
should be included and maintained among the strategies
to be followed in order to attain the goal of elimination of
this preventable disease.
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